Suchergebnisse - %22Research Support%2C N.I.H.%2C Extramural%22

PubPharm (43)

1

Specific CP110 Phosphorylation Sites Mediate Anaphase Catastrophe after CDK2 Inhibition : Evidence for Cooperation with USP33 Knockdown

enthalten in: Molecular cancer therapeutics | 2015

von Hu, S. | Lu, Y. | Orr, B. | +7

2

Combined Inhibition of Cyclin-Dependent Kinases (Dinaciclib) and AKT (MK-2206) Blocks Pancreatic Tumor Growth and Metastases in Patient-Derived Xenograft Models

enthalten in: Molecular cancer therapeutics | 2015

von Hu, C. | Dadon, T. | Chenna, V. | +7

3

CDKN2A/p16 Loss Implicates CDK4 as a Therapeutic Target in Imatinib-Resistant Dermatofibrosarcoma Protuberans

enthalten in: Molecular cancer therapeutics | 2015

von Eilers, G. | Czaplinski, J. | Mayeda, M. | +9

4

CDK-4 inhibitor P276 sensitizes pancreatic cancer cells to gemcitabine-induced apoptosis

enthalten in: Molecular cancer therapeutics | 2012

von Subramaniam, D. | Periyasamy, G. | Ponnurangam, S. | +7

5

Apigenin induces apoptosis in human leukemia cells and exhibits anti-leukemic activity in vivo

enthalten in: Molecular cancer therapeutics | 2012

von Budhraja, A. | Gao, N. | Zhang, Z. | +8

6

Akt/mTOR counteract the antitumor activities of cixutumumab, an anti-insulin-like growth factor I receptor monoclonal antibody

enthalten in: Molecular cancer therapeutics | 2011

von Shin, D. | Min, H. | El-Naggar, A. | +3

7

Radiosensitization of head and neck squamous cell carcinoma by a SMAC-mimetic compound, SM-164, requires activation of caspases

enthalten in: Molecular cancer therapeutics | 2011

von Yang, J. | McEachern, D. | Li, W. | +9

8

PS-341 and histone deacetylase inhibitor synergistically induce apoptosis in head and neck squamous cell carcinoma cells

enthalten in: Molecular cancer therapeutics | 2010

von Kim, J. | Guan, J. | Chang, I. | +3

9

Induction of clusterin by AKT--role in cytoprotection against docetaxel in prostate tumor cells

enthalten in: Molecular cancer therapeutics | 2010

von Zhong, B. | Sallman, D. | Gilvary, D. | +7

10

IFNgamma restores breast cancer sensitivity to fulvestrant by regulating STAT1, IFN regulatory factor 1, NF-kappaB, BCL2 family members, and signaling to caspase-dependent apoptosis

enthalten in: Molecular cancer therapeutics | 2010

von Ning, Y. | Riggins, R. | Mulla, J. | +3

1
2
3
4
5
Nächster »
[5]